BioAge Labs Revenue and Competitors
Estimated Revenue & Valuation
- BioAge Labs's estimated annual revenue is currently $16.1M per year.
- BioAge Labs's estimated revenue per employee is $155,000
- BioAge Labs's total funding is $294M.
Employee Data
- BioAge Labs has 104 Employees.
- BioAge Labs grew their employee count by 9% last year.
BioAge Labs's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CEO | Reveal Email/Phone |
2 | CMO and EVP Research | Reveal Email/Phone |
3 | VP Program Management | Reveal Email/Phone |
4 | VP, Translational Aging Biology | Reveal Email/Phone |
5 | VP Media | Reveal Email/Phone |
6 | SVP, People | Reveal Email/Phone |
7 | VP, CMC | Reveal Email/Phone |
8 | SVP Regulatory Affairs & QA | Reveal Email/Phone |
9 | SVP, Clinical Science | Reveal Email/Phone |
10 | VP Data Science | Reveal Email/Phone |
BioAge Labs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BioAge Labs?
BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases. We've built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant -omics data that is tied to detailed medical follow-up records over their lifespan. To date, BioAge has raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. Recently, BioAge in-licensed our first two platform assets, and for both programs we'll be initiating Phase 2 efficacy trials by H1 2021. Our mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan. For additional information about BioAge, visit the company's website at www.bioagelabs.com
keywords:N/A
$294M
Total Funding
104
Number of Employees
$16.1M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioAge Labs News
(BUSINESS WIRE) BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend...
BioAge Labs, a biotech company developing therapeutics that target the molecular causes of muscle aging to extend healthy human lifespan,...
Dr. Fortney is the CEO and co-founder of BioAge Labs, a clinical stage drug discovery company in Richmond, CA. BioAge utilizes longitudinal...
Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19 OSAKA, Japan, March, 23 and 23, 2021 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D. hereafter "Shionogi") today announced that BioAge Labs ...
Notice regarding an initiation of Phase 2 clinical trial by BioAge aimed at treating older patients of COVID-19 OSAKA, Japan, March, 23 and 23, 2021 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D. hereafter "Shionogi") today announced that BioAge Labs ...
Other Companies in Richmond
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26M | 104 | 5% | N/A |
#2 | N/A | 104 | 4% | N/A |
#3 | $15.1M | 104 | 5% | N/A |
#4 | $28.1M | 104 | 4% | N/A |
#5 | $18.9M | 105 | 5% | N/A |